Stevanato Group S.p.A STVN
NYSE STVN
$20.92 +0.68 (+3.36%)
As of: Sep 10, 2026 · 3:59 PM EDT

Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026)

Stevanato Group S.p.A's (STVN) quarterly Research & Development came in at $7.2 million in Q2 2026, up 5.52% year-over-year from $6.8 million in Q2 2025, and up 5.57% quarter-over-quarter from $6.8 million in Q1 2026.

Analysis

Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Research & Development for 7 consecutive years, with $7.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Research & Development rose 5.52% year-over-year to $7.2 million in Q2 2026; TTM through Jun 2026 was $29.8 million, a 13.03% increase from a year earlier, with the FY2025 full-year figure at $29.6 million, down 12.5% from the prior year.
  • Research & Development was $7.2 million for Q2 2026 at Stevanato Group S.p.A, up from $6.8 million in the prior quarter.
  • Over five years, Research & Development peaked at $11.7 million in Q1 2024 and troughed at $6.0 million in Q4 2024.
  • A 5-year average of $8.4 million and a median of $8.8 million in 2022 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development gained 27.3% in 2024 and slumped 46.6% in 2025, its largest moves.
  • Over 5 years, Research & Development stood at $10.8 million in 2022, then climbed by 0.48% to $10.9 million in 2023, then slumped by 44.93% to $6.0 million in 2024, then grew by 12.82% to $6.8 million in 2025, then gained by 6.95% to $7.2 million in 2026.
  • The last three Research & Development figures came in at $7.2 million (Q2 2026), $6.8 million (Q1 2026), and $6.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Becton Dickinson 48.41 Bn 47.55 Bn 2.32 Bn 258.00 Mn
2 Medline 27.78 Bn 25.10 Bn 2.22 Bn -
3 West Pharmaceutical Services 24.42 Bn 23.98 Bn 329.20 Mn 19.70 Mn
4 Baxter International 12.49 Bn 10.34 Bn 1.03 Bn 129.00 Mn
5 Stevanato Group S.p.A 5.70 Bn 5.59 Bn 100.91 Mn 7.22 Mn
6 Acme United 235.29 Mn 230.25 Mn 26.69 Mn -
7 Rockwell Medical 31.39 Mn 6.60 Mn 3.24 Mn 577,000.00
8 Retractable Technologies 21.15 Mn -18.72 Mn 190,852.00 1.53 Mn
9 United Health Products 8.85 Mn 8.82 Mn - 3,852.00
10 Cuprina Holdings (Cayman) 7.88 Mn 4.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.22 Mn
Mar 31, 2026 6.84 Mn
Dec 31, 2025 6.75 Mn
Sep 30, 2025 8.94 Mn
Jun 30, 2025 6.84 Mn
Mar 31, 2025 6.24 Mn
Dec 31, 2024 5.98 Mn
Sep 30, 2024 7.26 Mn
Jun 30, 2024 9.41 Mn
Mar 31, 2024 11.68 Mn
Dec 31, 2023 10.87 Mn
Sep 30, 2023 9.46 Mn
Jun 30, 2023 9.11 Mn
Mar 31, 2023 9.18 Mn
Dec 31, 2022 10.81 Mn
Sep 30, 2022 7.68 Mn
Jun 30, 2022 9.07 Mn
Mar 31, 2022 8.63 Mn
Dec 31, 2021 10.87 Mn
Sep 30, 2021 8.72 Mn